HDAC selective inhibitors (4SC)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHDAC selective inhibitors (4SC)
Drug Alias Nameepigenetic target inhibitors (4SC Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsCoronary Artery DiseaseStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companies4SC Discovery Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies4SC Discovery Gmbh
Active IndicationsN/A
Inactive IndicationsCoronary Artery DiseaseStroke

Other Information

ATC CodeN/A
Related LinksN/A